Search research articles
Contact Us
Filters
Showing results (141-150 of 153) with videos related to
Page
of 16
Sort By:
Bone Marrow Transplantation
|
October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease
A Tyndall, A Fassas, J Passweg, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
British Journal of Haematology
|
February 26, 2000
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM)
M Michallet, M L Tanguy, G Socié, et al.
Leukemia
|
July 21, 2006
International uniform response criteria for multiple myeloma
B G M Durie, J-L Harousseau, J S Miguel, et al.
Leukemia
|
November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Leukemia
|
December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 153) with videos related to
Sort By:
Page
of 16
Bone Marrow Transplantation
|
October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease
A Tyndall, A Fassas, J Passweg, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
British Journal of Haematology
|
February 26, 2000
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM)
M Michallet, M L Tanguy, G Socié, et al.
Leukemia
|
July 21, 2006
International uniform response criteria for multiple myeloma
B G M Durie, J-L Harousseau, J S Miguel, et al.
Leukemia
|
November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Leukemia
|
December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Page
of 16